| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |